Drug details
Biktarvy (bictegravir, emtricitabine, and tenofovir alafenamide tablets)
type of HIV, ART Combos
Biktarvy (bictegravir, emtricitabine, and tenofovir alafenamide) is a three-drug combination of a human immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor (INSTI), and two HIV-1 nucleoside analog reverse transcriptase inhibitors (NRTIs), and is indicated as a complete regimen for the treatment of HIV-1 infection in adults who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen for at least 3 months with no history of treatment failure and no known substitutions associated with resistance to the individual components of Biktarvy.
The drug is often used to treat HIV .
This drug may have the following side effects:
- nausea,
- loss of appetite,
- itching,
- dark urine,
- rash,
- vomiting,
- diarrhea,
- fever,
- chills,
- severe drowsiness,
- stomach pain,
- dizziness,
- joint pain,
- coughing,
- nervousness,
- fast or shallow breathing,
- unusual tiredness,
- fast, pounding or irregular heartbeat,
- irritability,
- trouble breathing,
- vision changes,
- severe tiredness,
- severe dizziness
- trouble speaking,
- change in the amount of urine,
- swollen lymph nodes,
- pink or bloody urine,
- yellowing of the eyes and skin (jaundice),
- blue or cold skin,
- muscle pain,
- slow or irregular heartbeat,
- unexplained weight loss,
- muscle aches or weakness,
- severe headaches,
- numbness or tingling of the hands, feet, arms, or legs,
- non-healing skin sores,
- heat intolerance,
- bulging eyes,
- unusual growth in the neck (goiter),
- difficulty swallowing,
- difficulty moving your eyes,
- dropping face,
- paralysis,
- swelling of the face, tongue, or throat, and
The following drugs are related to Biktarvy, either as a replacement or used together:
- Kivexa (abacavir and lamivudine film-coated tablets)
- Cabenuva (cabotegravir; rilpivirine extended-release injectable suspension)
- Vocabria (cabotegravir tablets for oral use)
- Symtuza (darunavir, cobicistat, emtricitabine, and tenofovir  alafenamide tablets)
- Delstrigo (doravirine, lamivudine, and tenofovir disoproxil fumarate tablets)
- Dovato (dolutegravir and lamivudine tablets)
- Pifeltro (doravirine tablets)
- Rukobia (fostemsavir extended-release tablets)